Related Articles
An LGR4 agonist activates the GSK‑3β pathway to inhibit RANK‑RANKL signaling during osteoclastogenesis in bone marrow‑derived macrophages
Syringetin suppresses osteoclastogenesis mediated by osteoblasts in human lung adenocarcinoma
Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
Peucedanum japonicum Thunb. ethanol extract suppresses RANKL‑mediated osteoclastogenesis
Calcineurin/NFAT signaling pathway mediates titanium particle‑induced inflammation and osteoclast formation by inhibiting RANKL and M‑CSF in vitro